BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17636313)

  • 1. HMGB1 interacts with human topoisomerase IIalpha and stimulates its catalytic activity.
    Stros M; Bacíková A; Polanská E; Stokrová J; Strauss F
    Nucleic Acids Res; 2007; 35(15):5001-13. PubMed ID: 17636313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis.
    Kwon Y; Shin BS; Chung IK
    J Biol Chem; 2000 Jun; 275(24):18503-10. PubMed ID: 10764786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determinants of the catalytic inhibition of human topoisomerase IIα by salicylate analogs and salicylate-based drugs.
    Bau JT; Kurz EU
    Biochem Pharmacol; 2014 Jun; 89(4):464-76. PubMed ID: 24695359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SET and transposase domain protein Metnase enhances chromosome decatenation: regulation by automethylation.
    Williamson EA; Rasila KK; Corwin LK; Wray J; Beck BD; Severns V; Mobarak C; Lee SH; Nickoloff JA; Hromas R
    Nucleic Acids Res; 2008 Oct; 36(18):5822-31. PubMed ID: 18790802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.
    Stros M; Polanská E; Struncová S; Pospísilová S
    Nucleic Acids Res; 2009 Apr; 37(7):2070-86. PubMed ID: 19223331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metnase mediates resistance to topoisomerase II inhibitors in breast cancer cells.
    Wray J; Williamson EA; Royce M; Shaheen M; Beck BD; Lee SH; Nickoloff JA; Hromas R
    PLoS One; 2009; 4(4):e5323. PubMed ID: 19390626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain.
    Qin Y; Meng L; Hu C; Duan W; Zuo Z; Lin L; Zhang X; Ding J
    Mol Cancer Ther; 2007 Sep; 6(9):2429-40. PubMed ID: 17876042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique paclitaxel-mediated modulation of the catalytic activity of topoisomerase IIalpha.
    Dhawan V; Swaffar DS
    Anticancer Drugs; 1999 Apr; 10(4):397-404. PubMed ID: 10378675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate specificity plays an important role in uncoupling the catalytic and scaffolding activities of rat testis DNA topoisomerase IIalpha.
    Bakshi R; Galande S; Muniyappa K
    J Biomol Struct Dyn; 2001 Apr; 18(5):749-60. PubMed ID: 11334111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fbxo28 promotes mitotic progression and regulates topoisomerase IIα-dependent DNA decatenation.
    Kratz AS; Richter KT; Schlosser YT; Schmitt M; Shumilov A; Delecluse HJ; Hoffmann I
    Cell Cycle; 2016 Dec; 15(24):3419-3431. PubMed ID: 27754753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic core of human topoisomerase IIα: insights into enzyme-DNA interactions and drug mechanism.
    Lindsey RH; Pendleton M; Ashley RE; Mercer SL; Deweese JE; Osheroff N
    Biochemistry; 2014 Oct; 53(41):6595-602. PubMed ID: 25280269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
    Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
    Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
    Minniti E; Byl JAW; Riccardi L; Sissi C; Rosini M; De Vivo M; Minarini A; Osheroff N
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4687-4693. PubMed ID: 28919339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA helicase A interacts with dsDNA and topoisomerase IIalpha.
    Zhou K; Choe KT; Zaidi Z; Wang Q; Mathews MB; Lee CG
    Nucleic Acids Res; 2003 May; 31(9):2253-60. PubMed ID: 12711669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metnase mediates chromosome decatenation in acute leukemia cells.
    Wray J; Williamson EA; Sheema S; Lee SH; Libby E; Willman CL; Nickoloff JA; Hromas R
    Blood; 2009 Aug; 114(9):1852-8. PubMed ID: 19458360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.
    Patel S; Jazrawi E; Creighton AM; Austin CA; Fisher LM
    Mol Pharmacol; 2000 Sep; 58(3):560-8. PubMed ID: 10953049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitotic chromosomes are constrained by topoisomerase II-sensitive DNA entanglements.
    Kawamura R; Pope LH; Christensen MO; Sun M; Terekhova K; Boege F; Mielke C; Andersen AH; Marko JF
    J Cell Biol; 2010 Mar; 188(5):653-63. PubMed ID: 20194637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-binding activity of rat DNA topoisomerase II α C-terminal domain contributes to efficient DNA catenation in vitro.
    Kawano S; Kato Y; Okada N; Sano K; Tsutsui K; Tsutsui KM; Ikeda S
    J Biochem; 2016 Mar; 159(3):363-9. PubMed ID: 26527691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha.
    Aoyama M; Grabowski DR; Dubyak GR; Constantinou AI; Rybicki LA; Bukowski RM; Ganapathi MK; Hickson ID; Ganapathi R
    Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):727-33. PubMed ID: 9841887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the catalytic function of topoisomerase II alpha through association with RNA.
    Park SW; Parrott AM; Fritz DT; Park Y; Mathews MB; Lee CG
    Nucleic Acids Res; 2008 Nov; 36(19):6080-90. PubMed ID: 18820297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.